Slc22a18 - solute carrier family 22 (organic cation transporter), member 18

Predicted to enable transmembrane transporter activity and ubiquitin protein ligase binding activity. Predicted to be involved in xenobiotic detoxification by transmembrane export across the plasma membrane. Predicted to act upstream of or within anion transport. Predicted to be located in apical plasma membrane; cytoplasm; and nuclear envelope. Predicted to be integral component of plasma membrane. Is expressed in several structures, including liver; metanephros; nervous system; placenta; and yolk sac. Human ortholog(s) of this gene implicated in breast cancer. Orthologous to human SLC22A18 (solute carrier family 22 member 18). [provided by Alliance of Genome Resources, Apr 2022]